1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
- Contribution to journal › Article
-
Mark
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
- Contribution to journal › Article
-
Mark
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer
- Contribution to journal › Article
- 2022
-
Mark
Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion
- Contribution to journal › Article
- 2021
-
Mark
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy : relationship with histopathological response and survival
- Contribution to journal › Article
- 2020
-
Mark
Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
- Contribution to journal › Article
-
Mark
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages
- Contribution to journal › Article
-
Mark
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
- Contribution to journal › Article
- 2019
-
Mark
Immunoprofiles of colorectal cancer from Lynch syndrome
- Contribution to journal › Article
-
Mark
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
- Contribution to journal › Article
